What is Medlen & Carroll?
Medlen & Carroll, LLP operates as a premier legal entity dedicated exclusively to intellectual property law across diverse technological domains. The firm distinguishes itself through a boutique specialization in the biosciences, where the complexity of patent law requires a deep understanding of scientific innovation. By employing professionals who possess both advanced technical degrees and significant industrial experience, the firm provides high-value representation in critical areas such as intellectual property acquisition, complex licensing agreements, and high-stakes litigation. This specialized focus allows Medlen & Carroll to serve as a strategic partner for technology-driven enterprises navigating the intricate regulatory and competitive environments of modern science.
How much funding has Medlen & Carroll raised?
Medlen & Carroll has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Medlen & Carroll
PPP
Public-Private Partnership
What's next for Medlen & Carroll?
Following this late-stage strategic investment, Medlen & Carroll is poised to scale its operations and deepen its influence within the bioscience intellectual property market. The firm is expected to utilize this capital to enhance its litigation capabilities and expand its advisory services for emerging biotech firms. As the demand for sophisticated IP protection grows in tandem with rapid advancements in life sciences, Medlen & Carroll is strategically aligned to capture increased market share. Future growth will likely focus on strengthening its bench of technical-legal experts and refining its proprietary approach to patent acquisition, ensuring the firm remains at the forefront of legal innovation in the technology sector.
See full Medlen & Carroll company page
